BE728658A - - Google Patents

Info

Publication number
BE728658A
BE728658A BE728658DA BE728658A BE 728658 A BE728658 A BE 728658A BE 728658D A BE728658D A BE 728658DA BE 728658 A BE728658 A BE 728658A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE728658A publication Critical patent/BE728658A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
BE728658D 1968-03-06 1969-02-19 BE728658A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB00906/68A GB1203691A (en) 1968-03-06 1968-03-06 New disubstituted n-amino indoline derivatives and process for preparing them

Publications (1)

Publication Number Publication Date
BE728658A true BE728658A (da) 1969-08-19

Family

ID=9976474

Family Applications (1)

Application Number Title Priority Date Filing Date
BE728658D BE728658A (da) 1968-03-06 1969-02-19

Country Status (13)

Country Link
US (1) US3565911A (da)
BE (1) BE728658A (da)
CH (1) CH507940A (da)
DE (1) DE1909180A1 (da)
DK (1) DK126193B (da)
ES (1) ES364421A1 (da)
FI (1) FI50119C (da)
FR (1) FR2003311A1 (da)
GB (1) GB1203691A (da)
IT (1) IT8049196A0 (da)
NL (1) NL145226B (da)
NO (1) NO128068B (da)
SE (1) SE334887B (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4112111A (en) * 1975-02-26 1978-09-05 Sandoz Ltd. Indolinylguanidines
IT1113879B (it) * 1979-03-15 1986-01-27 Farmatis Spa Derivato isoindolinico,processo per la sua preparazione e composizioni terapeutiche che lo comprendono come principio attivo
LU82949A1 (fr) * 1980-11-20 1981-06-04 Usv Pharma Corp Nouveaux amino-benzamides,leur procede de preparation et leur application au traitement de l'hypertension
DE3172386D1 (en) * 1980-12-22 1985-10-24 Usv Pharma Corp Synthesis of indolines
JPS57206657A (en) * 1981-06-16 1982-12-18 Mitsui Toatsu Chem Inc Sulfamoylbenzoic acid derivative and remedying composition containing said derivative as active component
FR2529785A1 (fr) * 1982-07-09 1984-01-13 Adir Composition pharmaceutique a base d'indapamide et de 8-(3-tertbutylamino 2-hydroxypropoxy)-thiachromanne
FR2663324B1 (fr) * 1990-06-14 1992-09-04 Adir Nouveau procede de preparation industrielle du 4-chloro 3-sulfamoyl n-(2,3-dihydro 2-methyl 1h-indol-1-yl) benzamide.
FR2663325B1 (fr) * 1990-06-14 1992-09-04 Adir Nouveau procede de preparation industrielle du 4-chloro 3-sulfamoyl n-(2,3-dihydro 2-methyl 1h-indol-1-yl) benzamide a partir de la 2,3-dihydro 2-methyl 1h-indole et de l'acide hydroxylamine-o-sulfonique.
FR2677886B1 (fr) * 1991-06-18 1995-03-31 Adir Comprime matriciel permettant la liberation prolongee d'indapamide apres administration par voie orale.
US5319096A (en) * 1992-04-03 1994-06-07 Hoechst-Roussel Pharmaceuticals Inc. (1H-indol-1-yl)-2-(amino) acetamides and related (1H-indol-1-yl)-(aminoalkyl)amides, pharmaceutical composition and use
IT1288123B1 (it) * 1996-09-04 1998-09-10 Nicox Sa Uso di nitroderivati per l'incontinenza urinaria
AP2005003232A0 (en) 2002-08-19 2005-03-31 Pfizer Prod Inc Combination therapy for hyperproliferative diseases.
US20060063803A1 (en) * 2004-09-23 2006-03-23 Pfizer Inc 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds
WO2006055542A2 (en) * 2004-11-15 2006-05-26 Nitromed, Inc. Diuretic compounds comprising heterocyclic nitric oxide donor groups, compositions and methods of use
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
CN101663262B (zh) 2006-12-01 2014-03-26 百时美施贵宝公司 用于治疗动脉粥样硬化和心血管疾病的作为cetp抑制剂的n-(3-苄基)-2,2-(二苯基)-丙-1胺衍生物
FR2924713B1 (fr) * 2007-12-11 2010-01-29 Servier Lab Nouveaux derives diazeniumdiolates, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
WO2011149438A1 (en) 2010-05-28 2011-12-01 Mahmut Bilgic Combination of antihypertensive agents
MX2015014666A (es) 2013-04-17 2016-03-01 Pfizer Derivados de n-piperidin-3-ilbenzamida para tratar enfermedades cardiovasculares.
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
EP3911648A4 (en) 2019-01-18 2022-10-26 Astrazeneca AB PCSK9 INHIBITORS AND METHODS OF USE THEREOF
WO2023001880A1 (en) 2021-07-22 2023-01-26 Krka, D. D., Novo Mesto Bilayer tablet comprising telmisartan and indapamide
EP4295839A1 (en) 2022-06-20 2023-12-27 KRKA, d.d., Novo mesto Combination of valsartan and indapamide

Also Published As

Publication number Publication date
IT8049196A0 (it) 1980-07-09
NL145226B (nl) 1975-03-17
US3565911A (en) 1971-02-23
DK126193B (da) 1973-06-18
CH507940A (fr) 1971-05-31
FI50119B (da) 1975-09-01
GB1203691A (en) 1970-09-03
FI50119C (fi) 1975-12-10
NL6903421A (da) 1969-09-09
SE334887B (da) 1971-05-10
ES364421A1 (es) 1971-02-01
DE1909180A1 (de) 1970-07-02
NO128068B (da) 1973-09-24
FR2003311A1 (da) 1969-11-07

Similar Documents

Publication Publication Date Title
AU1946070A (da)
AU428130B2 (da)
AU2374870A (da)
AU5184069A (da)
AU6168869A (da)
AU6171569A (da)
AU416157B2 (da)
AU429879B2 (da)
AU2581067A (da)
AU4811568A (da)
AU421558B1 (da)
AU3789668A (da)
AU3224368A (da)
AU4744468A (da)
AU2580267A (da)
AU4224469A (da)
BE708888A (da)
AU463027A (da)
AU4503667A (da)
AU479393A (da)
AU479894A (da)
AU4464266A (da)
AU4270368A (da)
BE709320A (da)
BE709435A (da)

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: SOC FRANCAISE DE RECHERCHE MEDICALE

Effective date: 19890219

Owner name: SCIENCE UNION & CIE

Effective date: 19890219